c-ABL-IN-3

CAT:

804-HY-146528

Size:

Inquire

Price:

Ask

For price, please contact [email protected]

CAS Number: 2626934-64-1
UNSPSC Description: c-ABL-IN-3 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-3 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 50)[1].
Target Antigen: Others
Type: Reference compound
Related Pathways: Others
Applications: Cancer-programmed cell death
Field of Research: Cancer; Neurological Disease
Assay Protocol: https://www.medchemexpress.com/c-abl-in-3.html
Solubility: 10 mM in DMSO
Smiles: O=C(C(C=C1)=CN(C2=CN=CN=C2)C1=O)NC3=CC=C(OC(F)(F)F)C=C3
Molecular Weight: 376.29
References & Citations: [1]Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
HY-146528	c-ABL-IN-3
HY-156102	c-ABL-IN-5
HY-146530	c-ABL-IN-4
HY-139730	c-ABL-IN-1
HY-146527	c-ABL-IN-2
HY-163189	c-ABL-IN-6
HY-136526	BCR-ABL-IN-3
HY-160174	BCR-ABL kinase-IN-3
HY-160174A	BCR-ABL kinase-IN-3 (dihydrocholide)
HY-153008	BCR-ABL-IN-7